Low applicability of the ''six-and-twelve score" in hepatocellular carcinoma treated with drug-eluting beads transarterial chemoembolization.
María Pipa-MuñizAndrés Castaño-GarcíaSusana SanmartinoAlicia MesaCarmen Álvarez-NavascuésMaría Luisa González-DiéguezValle Cadahía-RodrigoMario Ernesto Piscoya-DíazSerafín Marcos Costilla-GarcíaManuel RodríguezMaria VarelaPublished in: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (2021)
The ''Six-and-twelve score" is a prognostic tool for patients with HCC treated with DEB-TACE. However, few patients were included in the third group (score >12) and no differences were observed with BCLC, therefore its applicability is limited.